Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 1—January 2004
Dispatch

Salmonella Serovars from Humans and Other Sources in Thailand, 1993–2002

Aroon Bangtrakulnonth*, Srirat Pornreongwong*, Chaiwat Pulsrikarn*, Pathom Sawanpanyalert*, Rene S. Hendriksen†, Danilo M. A. Lo Fo Wong†, and Frank M. Aarestrup†Comments to Author 
Author affiliations: *World Health Organization National Salmonella and Shigella Centre, Bangkok, Thailand; †WHO Collaborating Center for Antimicrobial Resistance in Foodborne Pathogens, Copenhagen, Denmark

Main Article

Table 1

The 25 most common serovars of Salmonella isolates from humans reported annually, 1993–2002, Thailand

Serovar Y and no. of isolates (%) Total
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
Weltevreden 443
(13.5) 574
 (9.9) 816
(12.3) 337
(9.3) 335
(9.7) 485
(11.6) 862
(18.0) 660
(16.1) 657
(15.9) 322
(7.9) 5,491
(12.5)
Enteritidis 471
(14.3) 833
(14.4) 877
(13.2) 489
(13.4) 365
(10.5) 396
(9.5) 401
(8.4) 306
(7.5) 357
(8.6) 515
(12.6) 5,010
(11.4)
Anatum 146
(4.4) 397
(6.9) 568
(8.5) 229
(6.3) 298
(8.6) 320
(7.6) 235
(4.9) 412
(10.1) 340
(8.2) 318
(7.8) 3,263
(7.4)
Derby 368
(11.2) 650
(11.3) 576
(8.7) 277
(7.6) 252
(7.3) 251
(6.0) 141
(3.0) 156
(3.8) 111
(2.7) 107
(2.6) 2,889
(6.6)
1, 4, 5, 12:i:-ssp.I 193
(5.9) 272
(4.7) 422
(6.3) 355
(9.8) 212
(6.1) 228
(5.4) 248
(5.2) 248
(6.1) 336
(8.1) 290
(7.1) 2,804
(6.4)
Typhimurium 154
(4.7) 216
(3.7) 326
(4.9) 238
(6.5) 305
(8.8) 278
(6.6) 258
(5.4) 205
(5.0) 175
(4.2) 167
(4.1) 2,322
(5.3)
Rissen 54
(1.6) 162
(2.8) 222
(3.3) 143
(3.9) 295
(8.5) 246
(5.9) 317
(6.6) 287
(7.0) 259
(6.3) 334
(8.2) 2,319
(5.3)
Stanley 64
(1.9) 147
(2.5) 186
(2.8) 85
(2.3) 99
(2.9) 147
(3.5) 245
(5.1) 210
(5.1) 242
(5.9) 263
(6.4) 1,688
(3.8)
Panama 31
(0.9) 64
(1.1) 9
 (1.4) 80
(2.2) 173
(5.0) 172
(4.1) 264
(5.5) 209
(5.1) 160
(3.9) 230
(5.6) 1,474
(3.3)
Agona 118
(3.6) 215
(3.7) 236
(3.6) 103
(2.8) 102
(2.9) 76
(1.8) 95
(2.0) 76
(1.9) 75
(1.8) 90
(2.2) 1,096
(2.7)
Choleraesuis 99
(3.0) 87
(1.5) 139
(2.1) 122
(3.4) 68
(2.0) 118
(2.8) 92
(1.9) 69
(1.7) 85
(2.1) 186
(4.5) 1,065
(2.4)
Hadar 64
(1.9) 8
(1.4) 198
(3.0) 67
(1.8) 80
(2.3) 8
(2.0) 96
(2.0) 106
(2.6) 136
(3.3) 112
(2.7) 1,023
(2.3)
Paratyphi A 76
(2.3) 107
(1.9) 134
(2.0) 330
(9.1) 47
(1.4) 157
(3.8) 108
(2.3) 15
(0.4) 7
(1.7) 981
(2.2)
Krefeld 149
(4.5) 129
(2.2) 135
(2.0) 52
(1.4) 74
(2.1) 67
(1.6) 72
(1.5) 36
(0.9) 32
(0.8) 39
(1.0) 785
(1.8)
Paratyphi B var Java 31
(0.9) 40
(0.7) 66
(1.0) 46
(1.3) 61
(1.8) 56
(1.3) 113
(2.4) 120
(2.9) 117
(2.8) 48
(1.2) 698
(1.6)
Typhi 61
(1.9) 53
(0.9) 41
(0.6) 42
(1.2) 43
(1.2) 64
(1.5) 68
(1.4) 213
(5.2) 82
(2.0) 667
(1.5)
Virchow 52
(1.6) 69
(1.2) 77
(1.2) 28
(0.7) 35
(1.0) 45
(1.1) 89
(1.9) 70
(1.7) 102
(2.5) 79
(1.9) 646
(1.5)
Lexington 40
(1.2) 67
(1.2) 66
(1.0) 35
(1.0) 45
(1.3) 60
(1.4) 68
(1.4) 56
(1.4) 88
(2.1) 52
(1.3) 577
(1.3)
Blockley 82
(2.5) 78
(1.4) 53
(0.8) 27
(0.7) 20
(0.6) 49
(1.2) 45
(0.9) 56
(1.4) 47
(1.1) 41
(1.0) 498
(1.1)
Hvittingfoss 12
(0.4) 94
(1.6) 125
(1.9) 27
(0.7) 12
(0.3) 16
(0.4) 66
(1.4) 41
(1.0) 33
(0.8) 35
(0.9) 461
(1.0)
Senftenberg 62
(1.9) 126
(2.2) 64
(1.0) 16
(0.4) 28
(0.8) 37
(0.9) 29
(0.6) 20
(0.5) 26
(0.6) 44
(1.1) 452
(1.0)
Bovismorbificans 32
(1.0) 54
(0.9) 87
(1.3) 16
(0.4) 37
(1.1) 42
(1.0) 56
(1.2) 30
(0.7) 29
(0.7) 56
(1.4) 439
(1.0)
London 27
(0.8) 92
(1.6) 72
(1.1) 45
(1.2) 67
(1.9) 71
(1.7) 24
(0.5) 15
(0.4) 8
(0.2) 0
(0.0) 421
(1.0)
Schwarzengrund 0
(0.0) 9
(0.2) 3
(0.0) 3
(0.1) 6
(0.2) 26
(0.6) 76
(1.6) 99
(2.4) 98
(2.4) 52
(1.3) 372
(0.8)
Emek 31
(0.9) 38
(0.7) 56
(0.8) 29
(0.8) 29
(0.8) 51
(1.2) 30
(0.6) 26
(0.7) 27
(0.7) 30
(0.7) 347
(0.8)
Other 424
(12.9) 1,116
(19.3) 1,011
(15.2) 415
(11.4) 380
(11.0) 643
(15.4) 679
(14.2) 577
(14.1) 366
(8.9) 598
(14.6) 6,299
(14.3)
Total 3,284 5,770 6,647 3,636 3,468 4,184 4,777 4,090 4,134 4,097 44,087

Main Article

Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external